| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
101,990,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Tango Therapeutics is a newly organized blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses in the biotechnology sector.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
2,975,000 |
3,394,000 |
| Total Buy Value |
$0 |
$0 |
$19,891,250 |
$21,649,920 |
| Total People Bought |
0 |
0 |
2 |
3 |
| Total Buy Transactions |
0 |
0 |
5 |
11 |
| Total Shares Sold |
372,500 |
396,510 |
629,017 |
629,017 |
| Total Sell Value |
$3,530,850 |
$3,833,147 |
$6,136,391 |
$6,136,391 |
| Total People Sold |
2 |
6 |
6 |
6 |
| Total Sell Transactions |
4 |
12 |
15 |
15 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Huang Alan |
Chief Scientific OfficerOffice |
• – – |
2021-08-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
135,887 |
|
- |
|
| Beckman Daniella |
Chief Financial OfficerOfficer |
• – – |
2021-08-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
63,867 |
|
- |
|
| Bctg Holdings, Llc |
10% Owner |
– – • |
2020-11-20 |
4 |
S |
$0.01 |
$30 |
D/D |
(5,000) |
4,488,450 |
|
- |
|
| Bctg Holdings, Llc |
10% Owner |
– – • |
2020-09-08 |
4 |
B |
$10.00 |
$5,335,000 |
D/D |
533,500 |
4,493,450 |
2.45 |
- |
|
| Bctg Holdings, Llc |
10% Owner |
– – • |
2020-09-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,959,950 |
|
- |
|
| Christensen Jamie |
Director |
– • – |
2020-09-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
40,600 |
|
- |
|
| Heyman Richard A. |
Director |
– • – |
2020-09-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
40,600 |
|
- |
|
| Baum Charles M |
Director |
– • – |
2020-09-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
40,600 |
|
- |
|
58 Records found
|
|
Page 3 of 3 |
|
|
